Elangovan Vellaichamy

2.4k total citations
67 papers, 1.9k citations indexed

About

Elangovan Vellaichamy is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Elangovan Vellaichamy has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Elangovan Vellaichamy's work include Heart Failure Treatment and Management (12 papers), Advanced Glycation End Products research (12 papers) and Natural Antidiabetic Agents Studies (11 papers). Elangovan Vellaichamy is often cited by papers focused on Heart Failure Treatment and Management (12 papers), Advanced Glycation End Products research (12 papers) and Natural Antidiabetic Agents Studies (11 papers). Elangovan Vellaichamy collaborates with scholars based in India, United States and Israel. Elangovan Vellaichamy's co-authors include Kailash N. Pandey, Umadevi Subramanian, S. Govindasamy, M. Thiyagarajan, P. Venkatachalam, N. Geetha, S. Balakumar, S. Balasubramanian, Irith Gati and S. Govindasamy and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Elangovan Vellaichamy

66 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elangovan Vellaichamy India 26 473 369 349 336 177 67 1.9k
Gerardo García‐Rivas Mexico 32 1.0k 2.1× 314 0.9× 262 0.8× 647 1.9× 144 0.8× 117 2.8k
Ioana Bâldea Romania 28 394 0.8× 552 1.5× 522 1.5× 88 0.3× 51 0.3× 95 2.0k
Mohammad Reza Mehrabi Iran 20 383 0.8× 143 0.4× 246 0.7× 335 1.0× 254 1.4× 72 1.7k
Vincenzo Quagliariello Italy 27 543 1.1× 99 0.3× 145 0.4× 304 0.9× 180 1.0× 63 1.9k
Chandramohan Govindasamy Saudi Arabia 21 350 0.7× 245 0.7× 109 0.3× 73 0.2× 342 1.9× 135 1.6k
Joydeep Das India 18 456 1.0× 446 1.2× 218 0.6× 54 0.2× 141 0.8× 39 1.6k
Abdul Ahad Saudi Arabia 41 1.1k 2.4× 167 0.5× 185 0.5× 77 0.2× 200 1.1× 159 4.7k
Bang‐Le Zhang China 29 1.1k 2.4× 164 0.4× 440 1.3× 124 0.4× 49 0.3× 111 2.6k
Anuradha Dhanasekaran India 25 873 1.8× 146 0.4× 361 1.0× 113 0.3× 141 0.8× 62 2.1k
V. Vijaya Padma India 34 1.4k 2.9× 242 0.7× 251 0.7× 293 0.9× 211 1.2× 104 4.7k

Countries citing papers authored by Elangovan Vellaichamy

Since Specialization
Citations

This map shows the geographic impact of Elangovan Vellaichamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elangovan Vellaichamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elangovan Vellaichamy more than expected).

Fields of papers citing papers by Elangovan Vellaichamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elangovan Vellaichamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elangovan Vellaichamy. The network helps show where Elangovan Vellaichamy may publish in the future.

Co-authorship network of co-authors of Elangovan Vellaichamy

This figure shows the co-authorship network connecting the top 25 collaborators of Elangovan Vellaichamy. A scholar is included among the top collaborators of Elangovan Vellaichamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elangovan Vellaichamy. Elangovan Vellaichamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vellaichamy, Elangovan, et al.. (2025). CNP inhibits T3 - induced hypertrophic growth in H9c2 cells: Impact of HDAC inhibitor. Archives of Biochemistry and Biophysics. 775. 110648–110648.
2.
Vellaichamy, Elangovan, et al.. (2024). Mucoadhesive and drug release of cholic acid based thiomeric micelles and encapsulated silver and gold nanoparticles for anticancer studies. Colloids and Surfaces A Physicochemical and Engineering Aspects. 703. 135363–135363. 2 indexed citations
3.
4.
Kasthuri, Jayapalan, et al.. (2023). Evaluation of cytotoxic activity against A549 human lung cancer cells using green synthesized N-Cholyl D-Penicillamine encapsulated silver and gold nanoparticles. Inorganic Chemistry Communications. 153. 110834–110834. 10 indexed citations
5.
K., Rohith Vinod, et al.. (2017). In vitro studies of graphene oxide reinforced hydroxyapatite nanobiocomposite on human erythrocytes. AIP conference proceedings. 1832. 50127–50127. 3 indexed citations
6.
Vellaichamy, Elangovan, et al.. (2016). Differential expression and regulation of anti-hypertrophic genes Npr1 and Npr2 during β-adrenergic receptor activation-induced hypertrophic growth in rats. Molecular and Cellular Endocrinology. 433. 117–129. 9 indexed citations
7.
Balakumar, S., et al.. (2015). Iron Incorporated Hydroxyapatite for Orthopaedic Applications: Its Synthesis, Characterization and Biocompatibility Studies. 29(4). 322–326. 6 indexed citations
8.
Vellaichamy, Elangovan, et al.. (2014). Atrial natriuretic peptide (ANP) inhibits DMBA/croton oil induced skin tumor growth by modulating NF-κB, MMPs, and infiltrating mast cells in swiss albino mice. European Journal of Pharmacology. 740. 388–397. 14 indexed citations
9.
Vellaichamy, Elangovan, et al.. (2013). Preliminary phytochemical screening and antibacterial ofCardiospermum halicacabum L.. Advances in Applied Science Research. 4(5). 2 indexed citations
10.
Rajakumar, Perumal, et al.. (2013). Synthesis and cardio protective biological applications of glucodendrimers by H9C2 cell studies. Carbohydrate Polymers. 99. 403–414. 9 indexed citations
11.
Subramanian, Umadevi, et al.. (2013). Angiotensin-II down-regulates cardiac natriuretic peptide receptor-A mediated anti-hypertrophic signaling in experimental rat hearts.. PubMed. 51(1). 48–55. 17 indexed citations
12.
Gajendiran, Mani, et al.. (2012). Isoniazid loaded core shell nanoparticles derived from PLGA–PEG–PLGA tri-block copolymers: In vitro and in vivo drug release. Colloids and Surfaces B Biointerfaces. 104. 107–115. 52 indexed citations
13.
Subramanian, Umadevi, et al.. (2012). Studies on the Cardio Protective Role of Gallic Acid Against AGE-Induced Cell Proliferation and Oxidative Stress in H9C2 (2-1) Cells. Cardiovascular Toxicology. 12(4). 304–311. 31 indexed citations
14.
Mathivanan, N., et al.. (2011). Desmodium gangeticum root extract attenuates isoproterenol-induced cardiac hypertrophic growth in rats. Journal of Pharmacy & Pharmacognosy Research. 2(1). 129–137. 3 indexed citations
15.
Vellaichamy, Elangovan, Kiran Deep Kaur, & Kailash N. Pandey. (2006). Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A. Peptides. 28(4). 893–899. 38 indexed citations
16.
Vellaichamy, Elangovan, et al.. (2004). Reduced cGMP signaling activates NF-κB in hypertrophied hearts of mice lacking natriuretic peptide receptor-A. Biochemical and Biophysical Research Communications. 327(1). 106–111. 22 indexed citations
17.
Vellaichamy, Elangovan, et al.. (2003). Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. American Journal of Physiology-Renal Physiology. 285(4). F694–F702. 57 indexed citations
18.
Vellaichamy, Elangovan, Ron Kohen, & Esther Shohami. (2000). Neurological Recovery From Closed Head Injury is Impaired in Diabetic Rats. Journal of Neurotrauma. 17(11). 1013–1027. 13 indexed citations
19.
Vellaichamy, Elangovan, S. Govindasamy, N. Ramamoorthy, & K. Balasubramanian. (1995). In vitro studies on the anticancer activity of Bacopa monnieri. Fitoterapia. 66(3). 211–215. 70 indexed citations
20.
Vellaichamy, Elangovan, et al.. (1994). Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis. Cancer Letters. 87(1). 107–113. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerardo García‐Rivas Breakdown of academic impact, for papers by Ioana Bâldea Breakdown of academic impact, for papers by Mohammad Reza Mehrabi Breakdown of academic impact, for papers by Vincenzo Quagliariello Breakdown of academic impact, for papers by Chandramohan Govindasamy Breakdown of academic impact, for papers by Joydeep Das Breakdown of academic impact, for papers by Abdul Ahad Breakdown of academic impact, for papers by Bang‐Le Zhang Breakdown of academic impact, for papers by Anuradha Dhanasekaran Breakdown of academic impact, for papers by V. Vijaya Padma
Rankless by CCL
2026